Oncology

Latest News

Melanoma & Skin Cancer Awareness Month | Image credit: Waseem Ali Khan - stock.adobe.com
5 Things You Should Know About Skin Cancer

May 2nd 2025

As skin cancer rates continue to rise, here are 5 key facts every health care professional should know to improve prevention, early detection, and patient outcomes.

stethoscopewithcompass | Image Credit: © Talaj-stock.adobe.com
Patient Navigation Is Nonnegotiable in Cancer Care

May 1st 2025

Liver cancer - Sebastian Kaulitzki - stock.adobe.com.jpg
Elevated HLA-G Seen in HCC Driven by Viral Infections, Fatty Liver

May 1st 2025

Doctor carrying documentation for patient care | image credit: Kanisorn - stock.adobe.com.jpeg
NCODA Outlines New Patient-Centered Oncology Distribution Models

May 1st 2025

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com
New Developments Warrant Rethinking HCC Transplant Criteria

April 29th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Practices Need More Proactive Approaches to Influence Evolving Oncology Ecosystem
February 20th 2023

Practices Need More Proactive Approaches to Influence Evolving Oncology Ecosystem

Jonathan Coggins, MHA Lisa Langenderfer
Kashyap Patel, MD
February 20th 2023

Kashyap Patel, MD, Reflects on Progress in Addressing Disparities in Cancer Care

Interview by Mary Caffrey
To Expand Access to Cancer Expertise, Collaboration Is Key
February 20th 2023

To Expand Access to Cancer Expertise, Collaboration Is Key

Mark Stadler, BBA Sach Jain, MBA
Sashi Naidu, MD, Carolina Blood and Cancer Care Associates
February 17th 2023

Dr Sashi Naidu: NOLA Initiative Is Helping Overcome Fragmented Oncology Care

Maggie L. Shaw
At Carolina Blood and Cancer Care Associates, the No One Left Alone (NOLA) initiative is working to break down cancer health disparities among its patients by addressing the social determinants of health that may be preventing equitable access to care.
Patient filling out survey
February 15th 2023

Cancer Symptom Algorithm Identifies Patients at Greater Risk of ED Visits, Hospital Admissions

Rose McNulty
A novel algorithm based on patient-reported outcome questionnaires stratified patients by disease complexity and effectively identified those at a higher risk of having an acute care visit.
Dr Whitney Jones Discusses Multi-Cancer Early Detection Testing
February 11th 2023

Dr Whitney Jones Discusses Multi-Cancer Early Detection Testing

Hayden E. Klein Rose McNulty
Whitney Jones, MD, chief medical advisor at GRAIL Inc, discusses the PATHFINDER study of multi-cancer early detection testing.
Stethoscope and money
February 8th 2023

Breast Cancer Treatment Is Associated With Financial Toxicity Worldwide, Study Finds

Rose McNulty
The findings emphasize a need for policies that may offset the impact of direct and indirect costs for patients with breast cancer.
Black nurse and patient.
February 4th 2023

NCCN Launches Pilot Project Aiming to Measure, Implement Health Equity in Cancer Care Practices

Matthew Gavidia
Five leading academic cancer centers are assessing the feasibility of implementing the Health Equity Report Card pilot project as a tool that can both meaningfully and feasibly measure and report on equitable care practices.
FDA Approves Sacituzumab Govitecan for Pre-Treated HR+/HER2- Metastatic Breast Cancer
February 3rd 2023

FDA Approves Sacituzumab Govitecan for Pre-Treated HR+/HER2- Metastatic Breast Cancer

Rose McNulty
The approval is based on results from the phase 3 TROPiCS-02 trial demonstrating overall and progression survival benefits with sacituzumab govitecan compared with physician’s choice of single-agent chemotherapy.
Breast cancer
February 1st 2023

Study Suggests MRI Is the Best Breast Cancer Screening Modality for Dense Breasts

Rose McNulty
A review and meta-analysis published in the journal Radiology found MRI to be the most effective supplemental breast cancer screening method for women with dense breasts and negative mammogram results.
Artificial Intelligence May Help Differentiate Colon Carcinoma From Acute Diverticulitis
January 27th 2023

Artificial Intelligence May Help Differentiate Colon Carcinoma From Acute Diverticulitis

Rose McNulty
Colon carcinoma and acute diverticulitis have similar computed tomography imaging features that can make differential diagnosis difficult for radiologists, but a novel artificial intelligence assistance model was shown to help diagnostic accuracy.
Doctor comforting patient
January 24th 2023

Study Highlights Racial, Geographic Disparities in Timely Breast Cancer Care

Rose McNulty
The findings suggest that both high-risk patients and high-risk regions should be considered in clinical and policy strategies to facilitate timely breast cancer care.
Screenshot of Dr Alonso V. Pacheco in a video interview
January 21st 2023

CARG Chemotherapy Toxicity Tool Helps Patients Understand Risks, Says Dr Alonso V. Pacheco

Laura Joszt, MA Justina Petrullo
Patient quality of life can be improved through shared knowledge between doctors and patients in cancer care using the Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Tool calculator, which Rocky Mountain Cancer Centers piloted, explained Alonso V. Pacheco, MD, medical director and medical oncologist/hematologist, Rocky Mountain Cancer Centers.
Doctor Looking at Lung Scan
January 19th 2023

Interstitial Lung Abnormalities Impact OS in NSCLC Patients Receiving CRT, Adjuvant Durvalumab

Rose McNulty
Pretreatment interstitial lung abnormalities were associated with worse overall and cause-specific survival in Japanese patients receiving chemoradiotherapy followed by adjuvant durvalumab for locally advanced non–small-cell lung cancer.
Image of lungs
January 18th 2023

Real-World Data Confirm Safety, Efficacy of Durvalumab After CRT in NSCLC

Rose McNulty
A preplanned analysis of the PACIFIC-R confirms findings from the pivotal PACIFIC trial of durvalumab as consolidation therapy in unresectable NSCLC after chemoradiotherapy.
Image of lung cancer
January 16th 2023

TMB May Predict Success of Chemoradiation, Durvalumab in Locally Advanced NSCLC

Jared Kaltwasser
The findings on tumor mutational burden (TMB) may fill a gap in biomarkers for patients who have non–small cell lung cancer (NSCLC).
Susan Sabo-Wagner Describes the Importance of Socio-Cultural Competence in Oncology Care
January 15th 2023

Susan Sabo-Wagner Describes the Importance of Socio-Cultural Competence in Oncology Care

Justina Petrullo Allison Inserro
Susan Sabo-Wagner MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas, explained how cultural competency allows for better care delivery to patients with cancer.
PD-L1 Warrants Further Research as Biomarker for Endometrial Cancer Therapy Response
January 13th 2023

PD-L1 Warrants Further Research as Biomarker for Endometrial Cancer Therapy Response

Rose McNulty
A recent study found potential significance in PD-L1 analysis results for predicting immune treatment response in patients with advanced endometrial carcinoma.
screenshot of Dr Alonso V. Pacheco during a video interview
January 13th 2023

Dr Alonso V. Pacheco Discusses a Tool to Measure Chemotherapy Toxicity for Elderly Patients

Laura Joszt, MA Justina Petrullo
A tool to measure chemotherapy toxicity from the Cancer and Aging Research Group can help determine emergency department visits or hospitalization risk, especially for elderly patients, says Alonso V. Pacheco, MD, medical director and medical oncologist/hematologist, Rocky Mountain Cancer Centers.
Collaboration Between Oncology and Primary Care Can Improve Cancer Screening and Prevention, Says Susan Sabo-Wagner
January 8th 2023

Collaboration Between Oncology and Primary Care Can Improve Cancer Screening and Prevention, Says Susan Sabo-Wagner

Justina Petrullo Allison Inserro
Moving screening and prevention care more upstream can help make an impact by getting patients diagnosed with cancer earlier, said Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas.
Paul Thurmes, MD, medical oncologist and hematologist, Minnesota Oncology
December 21st 2022

Dr Paul Thurmes Addresses Gaps in Cancer Care

Pearl Steinzor
Paul Thurmes, MD, medical oncologist and hematologist, Minnesota Oncology, spoke on key responsibilities and approaches that are often lacking in cancer care.
Joseph Alvarnas, MD.
November 12th 2022

Dr Joseph Alvarnas: Cancer Care Equity Act Meets the Needs of Patients With Advanced Disease

Matthew Gavidia
Joseph Alvarnas, MD, vice president of government affairs at City of Hope and chief clinical adviser of AccessHope in Duarte, California, spoke on how the California Cancer Care Equity Act will allow oncologists to escalate the care of patients with advanced cancers toward established centers that can better meet their needs, as well as implications from the decision to exclude genomic testing coverage in the bill.
Aggregation Lets Independent Practices Compete and Grow
October 22nd 2022

Aggregation Lets Independent Practices Compete and Grow

Mary Caffrey
Lessons From the Pandemic to Scale Cancer Care Innovation
October 21st 2022

Lessons From the Pandemic to Scale Cancer Care Innovation

Allison Inserro
Coverage from the New York City presentation of the Institute for Value-Based Medicine, co-chaired by Emeline Aviki, MD, MBA, of Memorial Sloan Kettering Cancer Center (MSKCC), and Robert Daly, MD, MBA, medical oncologist and lung cancer specialist at MSKCC.
Coverage From the Rutgers Pharmacy Conference
October 20th 2022

Coverage From the Rutgers Pharmacy Conference

Matthew Gavidia
Featured coverage from the 70th Annual Roy A. Bowers Pharmaceutical Conference, held September 19, 2022. The theme for the 2022 conference was Innovation Through Crisis: Redefining Health Care Delivery.
The Promise of Telehealth—a Cautionary Tale
October 20th 2022

The Promise of Telehealth—a Cautionary Tale

Neil Minkoff, MD Joshua Greenblatt, BFA Yana Volman, MBA
Implications of Telehealth Use on the Future of Oncology Care
cancer.
October 15th 2022

Growing Innovation, Cost Expected in the Oncology Drug Pipeline

Matthew Gavidia
The concluding keynote address at the Academy of Managed Care Pharmacy Nexus 2022 meeting discussed new and emerging oncology drugs in the pipeline and their potential impact on the treatment landscape as it pertains to managed care providers.
Technology Is on Tap at ACCC National Oncology Conference
October 11th 2022

Technology Is on Tap at ACCC National Oncology Conference

Mary Caffrey
The sessions align with the yearlong theme selected by this year’s ACCC president, David R. Penberthy, MD, MBA, when he took the helm in March: “Leveraging Technology to Transform Cancer Care Delivery and the Patient Experience.”
Site Logo
October 7th 2022

Practice Radiation Patterns Among Oncologists in the Oncology Care Model

Brigham Walker, PhD Vivek Kavadi, MD Lalan Wilfong, MD Nicholas Robert, MD
Despite the potential incentives for medical oncologists to reduce radiation therapy utilization under the Oncology Care Model, we find no evidence that such reduction occurred.
Lucy Langer, MD, MSHS
October 6th 2022

There Needs to Be an Arbiter of High-Quality, High-Value Cancer Care, Says Dr Lucy Langer

Laura Joszt, MA
With multiple pathways and stakeholders involved, there needs to be an arbiter who decides what is the highest quality and highest value care in oncology, said Lucy Langer, MD, MSHS, national medical director, oncology and genomics, UnitedHealthcare.
<1
...
91011121314151617
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo